7-(2-Chloro-2-phenylethyl)-2-(methylthio)-N-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

ID: ALA4103914

PubChem CID: 137657483

Max Phase: Preclinical

Molecular Formula: C21H19ClN4S

Molecular Weight: 394.93

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CSc1nc(Nc2ccccc2)c2ccn(CC(Cl)c3ccccc3)c2n1

Standard InChI:  InChI=1S/C21H19ClN4S/c1-27-21-24-19(23-16-10-6-3-7-11-16)17-12-13-26(20(17)25-21)14-18(22)15-8-4-2-5-9-15/h2-13,18H,14H2,1H3,(H,23,24,25)

Standard InChI Key:  FJQQPDTVQFJFJW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    9.9102  -17.2296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6285  -17.6324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3356  -17.2105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3245  -16.3856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6063  -15.9827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8949  -16.4048    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1259  -17.4518    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1080  -16.1190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6016  -16.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5952  -15.1579    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8728  -14.7551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8617  -13.9303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1394  -13.5275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4322  -13.9494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4433  -14.7743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1657  -15.1771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1989  -17.6516    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.4806  -17.2488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3925  -18.2353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2027  -18.3939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4265  -19.1895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8530  -19.7785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0768  -20.5741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8740  -20.7764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4515  -20.1832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2278  -19.3918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7463  -17.7732    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  8  9  2  0
  7  9  1  0
  3  7  1  0
  4  8  1  0
  5 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
 10 11  1  0
 17 18  1  0
  1 17  1  0
 19 20  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 21 26  2  0
 20 21  1  0
 20 27  1  0
  7 19  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4103914

    ---

Associated Targets(Human)

FYN Tclin Tyrosine-protein kinase FYN (5308 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.93Molecular Weight (Monoisotopic): 394.1019AlogP: 5.88#Rotatable Bonds: 6
Polar Surface Area: 42.74Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.46CX LogP: 6.53CX LogD: 6.52
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.25Np Likeness Score: -1.35

References

1. Musumeci F, Fallacara AL, Brullo C, Grossi G, Botta L, Calandro P, Chiariello M, Kissova M, Crespan E, Maga G, Schenone S..  (2017)  Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.,  127  [PMID:28076826] [10.1016/j.ejmech.2016.12.036]

Source